CURRENT MOLECULAR PHARMACOLOGY : Impact Factor & More
eISSN: 1874-4702pISSN: 1874-4672
Share this on:
Key Metrics
Impact Factor 
< 5
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on CURRENT MOLECULAR PHARMACOLOGY
CURRENT MOLECULAR PHARMACOLOGY Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in CURRENT MOLECULAR PHARMACOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in CURRENT MOLECULAR PHARMACOLOGY
Metabolic Reprogramming and Epigenetic Regulation: The Dual Role of Lactate and Lactylation in Pancreatic Ductal Adenocarcinoma Progression and Therapeutics
- 1 Apr 2026
- Current Molecular Pharmacology
Oncology Drug Resistance Prediction Tools: Database Infrastructure, Algorithmic Innovation, and Clinical Translation
- 1 Apr 2026
- Current Molecular Pharmacology
Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis
- 1 Apr 2026
- Current Molecular Pharmacology
Lactobacillus rhamnosus CMU-pb-7 Alleviates Diabetic Nephropathy in a High-Fat Diet-Streptozotocin Rat Model
- 1 Mar 2026
- Current Molecular Pharmacology
Gramine suppresses triple-negative breast cancer by inducing ferroptosis via CUL3-mediated ubiquitination of MTDH
- 1 Jan 2026
- Current Molecular Pharmacology
Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs
- 1 Jan 2026
- Current Molecular Pharmacology
Metabolic Reprogramming and Epigenetic Regulation: The Dual Role of Lactate and Lactylation in Pancreatic Ductal Adenocarcinoma Progression and Therapeutics
- 1 Apr 2026
- Current Molecular Pharmacology
Oncology Drug Resistance Prediction Tools: Database Infrastructure, Algorithmic Innovation, and Clinical Translation
- 1 Apr 2026
- Current Molecular Pharmacology
Integrative transcriptomic and metabolomic analyses of puerarin against cholestatic liver fibrosis
- 1 Apr 2026
- Current Molecular Pharmacology
Lactobacillus rhamnosus CMU-pb-7 Alleviates Diabetic Nephropathy in a High-Fat Diet-Streptozotocin Rat Model
- 1 Mar 2026
- Current Molecular Pharmacology
Gramine suppresses triple-negative breast cancer by inducing ferroptosis via CUL3-mediated ubiquitination of MTDH
- 1 Jan 2026
- Current Molecular Pharmacology
Targeting fPRDM16 to restore collagen phagocytosis: A mechanism to counteract the persistent fibrosis in aging lungs
- 1 Jan 2026
- Current Molecular Pharmacology
FAQs on CURRENT MOLECULAR PHARMACOLOGY
How long has CURRENT MOLECULAR PHARMACOLOGY been actively publishing? 
What is the publishing frequency of CURRENT MOLECULAR PHARMACOLOGY?
How many articles did CURRENT MOLECULAR PHARMACOLOGY publish last year?
What is the eISSN & pISSN for CURRENT MOLECULAR PHARMACOLOGY?
Who is the publisher of CURRENT MOLECULAR PHARMACOLOGY?
